Clinics of ocular tuberculosis: A review.
mycobacteria
ocular tuberculosis
tuberculosis
uveitis
Journal
Clinical & experimental ophthalmology
ISSN: 1442-9071
Titre abrégé: Clin Exp Ophthalmol
Pays: Australia
ID NLM: 100896531
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
07
07
2020
revised:
16
08
2020
accepted:
18
08
2020
pubmed:
12
1
2021
medline:
1
9
2021
entrez:
11
1
2021
Statut:
ppublish
Résumé
Ocular tuberculosis (OTB) is an extrapulmonary mycobacterial infection, which still sees variations in incidence, manifestations, diagnostic and therapeutic approaches. While the disease is gaining more recognition as a differential in ocular inflammation, it remains a difficult entity to detect and treat. Global efforts to synthesize and standardize the approach to OTB could prove useful in delivering quicker, more effective care. We summarize recent insights in appropriate nomenclature, clinical presentations, diagnostic modalities and courses of treatment.
Substances chimiques
Antitubercular Agents
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
146-160Informations de copyright
© 2021 Royal Australian and New Zealand College of Ophthalmologists.
Références
Agrawal R, Gunasekeran DV, Grant R, et al. Collaborative ocular tuberculosis study −1 study G. clinical features and outcomes of patients with tubercular uveitis treated with antitubercular therapy in the Collaborative Ocular Tuberculosis Study (COTS)-1. JAMA Ophthalmol. 2017;135:1318-1327.
Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2017;101:6-9.
Agrawal R, Gunasekeran DV, Raje D, et al. Global variations and challenges with tubercular uveitis in the Collaborative Ocular Tuberculosis Study. Invest Ophthalmol Vis Sci. 2018;59:4162-4171.
Figueira L, Fonseca S, Ladeira I, Duarte R. Ocular tuberculosis: position paper on diagnosis and treatment management. Rev Port Pneumol (2006). 2017;23:31-38.
Lee C, Agrawal R, Pavesio C. Ocular tuberculosis-a clinical conundrum. Ocul Immunol Inflamm. 2016;24:237-242.
Ang M, Vasconcelos-Santos DV, Sharma K, et al. Diagnosis of ocular tuberculosis. Ocul Immunol Inflamm. 2018;26:208-216.
Gupta V, Shoughy SS, Mahajan S, et al. Clinics of ocular tuberculosis. Ocul Immunol Inflamm. 2015;23:14-24.
Gupta V, Gupta A, Rao NA. Intraocular tuberculosis-an update. Surv Ophthalmol. 2007;52:561-587.
Luca C, Raffaella A, Sylvia M, et al. Changes in patterns of uveitis at a tertiary referral center in northern Italy: analysis of 990 consecutive cases. Int Ophthalmol. 2018;38:133-142.
Zagora SL, Symes R, Yeung A, Yates W, Wakefield D, McCluskey PJ. Etiology and clinical features of ocular inflammatory diseases in a tertiary referral centre in Sydney, Australia. Ocul Immunol Inflamm. 2017;25:S107-S114.
Biswas J, Kharel Sitaula R, Multani P. Changing uveitis patterns in South India-comparison between two decades. Indian J Ophthalmol. 2018;66:524-527.
Al Dhahri H, Al Rubaie K, Hemachandran S, et al. Patterns of uveitis in a university-based tertiary referral center in Riyadh, Saudi Arabia. Ocul Immunol Inflamm. 2015;23:311-319.
Pandey TR, Kharel R, Shah DN, Pant RP. Pattern of presumed tuberculous uveitis in a tertiary eye care centre of Nepal. Cogent Med. 2018;5:1510302.
Kianersi F, Mohammadi Z, Ghanbari H, Ghoreyshi SM, Karimzadeh H, Soheilian M. Clinical patterns of uveitis in an Iranian tertiary eye-care center. Ocul Immunol Inflamm. 2015;23:278-282.
Amin RM, Goweida M, Bedda A, Kamel A, Radwan A. Clinical patterns and causes of intraocular inflammation in a uveitis patient cohort from Egypt. Ocul Immunol Inflamm. 2019;27:859-867.
Nguyen M, Siak J, Chee SP, Diem VQH. The spectrum of uveitis in southern Vietnam. Ocul Immunol Inflamm. 2017;25:S100-s6.
Vos AG, Wassenberg MW, de Hoog J, Oosterheert JJ. Diagnosis and treatment of tuberculous uveitis in a low endemic setting. Int J Infect Dis. 2013;17:e993-e999.
Nakahara H, Kaburaki T, Takamoto M, et al. Statistical analyses of endogenous uveitis patients (2007-2009) in Central Tokyo area and comparison with previous studies (1963-2006). Ocul Immunol Inflamm. 2015;23:291-296.
Llorenç Bellés V, Adán Civera A, Espinosa Garriga G, et al. Uveitis diagnosis characterization at a referral centre in the area of Barcelona, Spain. Med Clin (Barc). 2012;138:277-282.
Ducommun MA, Eperon S, Khonkarly MB, Cavassini M, Guex-Crosier Y. Long-term close follow-up of chorioretinal lesions in presumed ocular tuberculosis. Eur J Ophthalmol. 2012;22:195-202.
Abdulaal M, Antonios R, Barikian A, Jaroudi M, Hamam RN. Etiology and clinical features of ocular inflammatory diseases in a tertiary Center in Lebanon. Ocul Immunol Inflamm. 2015;23:271-277.
Sanghvi C, Bell C, Woodhead M, Hardy C, Jones N. Presumed tuberculous uveitis: diagnosis, management, and outcome. Eye (Lond). 2011;25:475-480.
Abu El-Asrar AM, Al-Mezaine HS. Anti-tuberculous therapy combined with systemic corticosteroids improves retinal sensitivity in patients with active presumed tuberculous choroiditis. Int Ophthalmol. 2010;30:567-576.
Kazokoglu H, Onal S, Tugal-Tutkun I, et al. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285-293.
Pathanapitoon K, Kunavisarut P, Ausayakhun S, Sirirungsi W, Rothova A. Uveitis in a tertiary ophthalmology Centre in Thailand. Br J Ophthalmol. 2008;92:474-478.
Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173-183.
Khairallah M, Yahia SB, Ladjimi A, et al. Pattern of uveitis in a referral Centre in Tunisia, North Africa. Eye (Lond). 2007;21:33-39.
Sengün A, Karadağ R, Karakurt A, Saricaoğlu MS, Abdik O, Hasiripi H. Causes of uveitis in a referral hospital in Ankara, Turkey. Ocul Immunol Inflamm. 2005;13:45-50.
Yang P, Zhang Z, Zhou H, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2005;30:943-948.
Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M. Patterns of uveitis in a tertiary eye care center in Iran. Ocul Immunol Inflamm. 2004;12:297-310.
Singh R, Gupta V, Gupta A. Pattern of uveitis in a referral eye clinic in North India. Indian J Ophthalmol. 2004;52:121-125.
Wakabayashi T, Morimura Y, Miyamoto Y, Okada AA. Changing patterns of intraocular inflammatory disease in Japan. Ocul Immunol Inflamm. 2003;11:277-286.
Islam SM, Tabbara KF. Causes of uveitis at the eye Center in Saudi Arabia: a retrospective review. Ophthalmic Epidemiol. 2002;9:239-249.
Shirley K, Dowlut S, Silvestri J, Pavesio C, Foot B. Presumed ocular tuberculosis in the United Kingdom: a British ophthalmological surveillance unit (BOSU) study. Eye (Lond). 2020;34:1835-1841.
Krassas N, Wells J, Bell C, Woodhead M, Jones N. Presumed tuberculosis-associated uveitis: rising incidence and widening criteria for diagnosis in a non-endemic area. Eye (Lond). 2018;32:87-92.
Agrawal R, Agarwal A, Jabs DA, et al. Standardization of nomenclature for ocular tuberculosis-results of Collaborative Ocular Tuberculosis Study (COTS) workshop. Ocul Immunol Inflamm. 2019;1-11. [Epub ahead of print].
Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature working G. standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140:509-516.
Gunasekeran DV, Agrawal R, Agarwal A, et al. THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1: a multinational review of 251 patients with tubercular retinal Vasculitis. Retina. 2019;39:1623-1630.
Testi I, Agrawal R, Mahajan S, et al. Tubercular uveitis: nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1. Ocul Immunol Inflamm. 2019;1-9. [Epub ahead of print].
Llorenc V, Benejam G, Mesquida M, et al. Antituberculous treatment itself might prevent visual impairment in presumed tuberculosis-related uveitis. Ocul Immunol Inflamm. 2020;28:103-110.
La Distia NR, van Velthoven ME, Ten Dam-van Loon NH, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON-TB gold in-tube test in a country nonendemic for tuberculosis. Am J Ophthalmol. 2014;157:754-761.
Gunasekeran DV, Gupta B, Cardoso J, Pavesio CE, Agrawal R. Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population. Ocul Immunol Inflamm. 2018;26:865-869.
Al-Qarni A, Abouammoh MA, Almousa AN, Mousa A, Abu El-Asrar AM. Presumed tuberculous uveitis in a university-based tertiary referral center in Saudi Arabia. Int Ophthalmol. 2019;39:317-333.
Basu S, Monira S, Modi RR, et al. Degree, duration, and causes of visual impairment in eyes affected with ocular tuberculosis. J Ophthalmic Inflamm Infect. 2014;4:3.
Manousaridis K, Ong E, Stenton C, Gupta R, Browning AC, Pandit R. Clinical presentation, treatment, and outcomes in presumed intraocular tuberculosis: experience from Newcastle upon Tyne, UK. Eye (Lond). 2013;27:480-486.
Khochtali S, Gargouri S, Abroug N, et al. The spectrum of presumed tubercular uveitis in Tunisia, North Africa. Int Ophthalmol. 2015;35:663-671.
Al-Mezaine HS, Al-Muammar A, Kangave D, Abu El-Asrar AM. Clinical and optical coherence tomographic findings and outcome of treatment in patients with presumed tuberculous uveitis. Int Ophthalmol. 2008;28:413-423.
Agrawal R, Betzler BK, Testi IM, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1: a multinational review of 165 patients with tubercular anterior uveitis. Ocul Immunol Inflamm. 2020;1-10. [Epub ahead of print].
Alvarez GG, Roth VR, Hodge W. Ocular tuberculosis: diagnostic and treatment challenges. Int J Infect Dis. 2009;13:432-435.
Gupta V, Gupta A, Arora S, Bambery P, Dogra MR, Agarwal A. Presumed tubercular serpiginouslike choroiditis: clinical presentations and management. Ophthalmology. 2003;110:1744-1749.
Bansal R, Gupta A, Gupta V, Dogra MR, Sharma A, Bambery P. Tubercular serpiginous-like choroiditis presenting as multifocal serpiginoid choroiditis. Ophthalmology. 2012;119:2334-2342.
Babu K, Mukhopadhyay M, Bhat SS, Chinmayee J. Orbital and adnexal tuberculosis: a case series from a south Indian population. J Ophthalmic Inflamm Infect. 2014;4:12.
Tabbara KF. Ocular tuberculosis: anterior segment. Int Ophthalmol Clin. 2005;45:57-69.
Chaurasia S, Ramappa M, Murthy SI, et al. Chronic conjunctivitis due to Mycobacterium tuberculosis. Int Ophthalmol. 2014;34:655-660.
Kaur S, Aggarwal K, Agarwal A, et al. Clinical course and outcomes of pediatric tubercular uveitis in North India. Ocul Immunol Inflamm. 2018;26:859-864.
Babu RB, Sudharshan S, Kumarasamy N, Therese L, Biswas J. Ocular tuberculosis in acquired immunodeficiency syndrome. Am J Ophthalmol. 2006;142:413-418.
Urzua CA, Lantigua Y, Abuauad S, et al. Clinical features and prognostic factors in presumed ocular tuberculosis. Curr Eye Res. 2017;42:1029-1034.
Patel SS, Saraiya NV, Tessler HH, Goldstein DA. Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity. JAMA Ophthalmol. 2013;131:752-758.
Anibarro L, Cortes E, Chouza A, et al. Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study. Infection. 2018;46:549-554.
Jakob E, Max R, Zimmermann S, et al. Three years of experience with QuantiFERON-TB gold testing in patients with uveitis. Ocul Immunol Inflamm. 2014;22:478-484.
Cimino L, Herbort CP, Aldigeri R, Salvarani C, Boiardi L. Tuberculous uveitis, a resurgent and underdiagnosed disease. Int Ophthalmol. 2009;29:67-74.
Agarwal A, Agrawal R, Gunasekaran DV, et al. The Collaborative Ocular Tuberculosis Study (COTS)-1 report 3: polymerase chain reaction in the diagnosis and Management of Tubercular Uveitis: global trends. Ocul Immunol Inflamm. 2019;27:465-473.
Albert DM, Raven ML. Ocular tuberculosis. Microbiol Spectr. 2016;4:313-330.
Diel R, Goletti D, Ferrara G, et al. Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88-99.
Sudharshan S, Ganesh SK, Balu G, et al. Utility of QuantiFERON(R)-TB gold test in diagnosis and management of suspected tubercular uveitis in India. Int Ophthalmol. 2012;32:217-223.
Gineys R, Bodaghi B, Carcelain G, et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol. 2011;152:433-440. e1.
Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med. 2013;188:1005-1010.
Ang M, Wong WL, Kiew SY, Li X, Chee SP. Prospective head-to-head study comparing 2 commercial interferon gamma release assays for the diagnosis of tuberculous uveitis. Am J Ophthalmol. 2014;157:1306-1314.e4.
Agrawal R, Grant R, Gupta B, et al. What does IGRA testing add to the diagnosis of ocular tuberculosis? BMC Ophthalmol. 2017;17:245.
Sharma K, Gupta V, Bansal R, Sharma A, Sharma M, Gupta A. Novel multi-targeted polymerase chain reaction for diagnosis of presumed tubercular uveitis. J Ophthalmic Inflamm Infect. 2013;3:25.
Sharma K, Gupta A, Sharma M, et al. MTBDRplus for the rapid diagnosis of ocular tuberculosis and screening of drug resistance. Eye (Lond). 2018;32:451-456.
Sudheer B, Lalitha P, Kumar AL, Rathinam S. Polymerase chain reaction and its correlation with clinical features and treatment response in tubercular uveitis. Ocul Immunol Inflamm. 2018;26:845-852.
Doycheva D, Deuter C, Hetzel J, et al. The use of positron emission tomography/CT in the diagnosis of tuberculosis-associated uveitis. Br J Ophthalmol. 2011;95:1290-1294.
Mehta S. Observed patterns of systemic disease on PET/CT scan in patients with presumed ocular tuberculosis: findings and hypotheses. Ocul Immunol Inflamm. 2018;26:217-219.
de Parisot A, Kodjikian L, Errera MH, et al. Randomized controlled trial evaluating a standardized strategy for uveitis etiologic diagnosis (ULISSE). Am J Ophthalmol. 2017;178:176-185.
Agrawal R, Gupta B, Gonzalez-Lopez JJ, et al. The role of anti-tubercular therapy in patients with presumed ocular tuberculosis. Ocul Immunol Inflamm. 2015;23:40-46.
Agrawal R, Testi I, Mahajan S, et al. Collaborative Ocular Tuberculosis Study Consensus Guidelines on the Management of Tubercular Uveitis-Report 1: Guidelines for Initiating Antitubercular therapy in Tubercular Choroiditis. Ophthalmology. 2020. [Epub ahead of print].
Agrawal R, Testi I, Bodaghi B, et al. Collaborative Ocular Tuberculosis Study (COTS) Consensus Guidelines on the Management of Tubercular Uveitis - Report 2: Guidelines for Initiating Anti-Tubercular Therapy in Anterior Uveitis, Intermediate Uveitis, Panuveitis and Retinal Vasculitis. Ophthalmology. 2020. [Epub ahead of print].
Kim KL, Park SP. Visual function test for early detection of ethambutol induced ocular toxicity at the subclinical level. Cutan Ocul Toxicol. 2016;35:228-232.
Shakarchi FI. Ocular tuberculosis: current perspectives. Clin Ophthalmol. 2015;9:2223-2227.
Gupta V, Bansal R, Gupta A. Continuous progression of tubercular serpiginous-like choroiditis after initiating antituberculosis treatment. Am J Ophthalmol. 2011;152:857-863.
Moreno C, Taverne J, Mehlert A, et al. Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol. 1989;76:240-245.
Agrawal R, Gunasekeran DM, Agarwal AM, et al. Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6. Ocul Immunol Inflamm. 2020;1-9. [Epub ahead of print].
Goletti D, Lindestam Arlehamn CS, Scriba TJ, et al. Can we predict tuberculosis cure? What tools are available? Eur Respir J. 2018;52:1801089.
Agarwal A, Agrawal R, Raje D, et al. Twenty-four month outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: defining the "cure" in ocular tuberculosis. Ocul Immunol Inflamm. 2020;1-9. [Epub ahead of print].
Testi I, Mahajan S, Agrawal R, et al. Management of Intraocular Infections in HIV. Ocul Immunol Inflamm. 2020;1-10. [Epub ahead of print].
Kee AR, Gonzalez-Lopez JJ, Al-Hity A, et al. Anti-tubercular therapy for intraocular tuberculosis: a systematic review and meta-analysis. Surv Ophthalmol. 2016;61:628-653.